What is GS-441524 ?

GS-441524 (abbreviated GS) is an experimental antiviral drug (nucleoside analog) used during field trial led by Dr. Niels Pedersen at UC Davis in 2017.

The drug exists in injectable and oral form under the names of various brands.

en_GBEN